AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

ROSUVASTATIN;EZETIMIBE in Zimbabwe

2 products registered with MCAZ β€” 2 active

Brand / ProductReg. No.HolderStatusExpires
ROSTATIN Z 10/20
CAPSULE; ORAL
2026/12.8/7323COSPHARM INVESTMENTS PVT LTDactive1 Mar 2031
ROSTATIN Z 10/10
CAPSULE; ORAL
2026/12.8/7322COSPHARM INVESTMENTS PVT LTDactive1 Mar 2031

ROSUVASTATIN;EZETIMIBE β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 2 registered products containing ROSUVASTATIN;EZETIMIBE, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track ROSUVASTATIN;EZETIMIBE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Rosuvastatin Ezetimibe β€” Zimbabwe (MCAZ) | AfricaRegulatory